Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), reflecting a deeper understanding of the condition that affects multiple bodily systems, including metabolism and hormonal balance. This change is particularly significant in India, where the prevalence of PCOS is increasing among adolescents and young women, with estimates ranging from 3.7% to over 22%. Experts argue that the previous name oversimplified the condition, leading many women to mistakenly associate it primarily with ovarian cysts. The new terminology aims to broaden the understanding of PMOS as a multisystem disorder that includes symptoms such as irregular periods, insulin resistance, and increased risks of type 2 diabetes and cardiovascular issues. Doctors believe this shift will not only enhance awareness and diagnosis but also reduce stigma, encouraging women to seek medical help earlier. Holistic management of PMOS involves a multidisciplinary approach, including endocrinologists, nutritionists, and mental health professionals, emphasizing the need for lifestyle changes alongside medical treatment.